Carpal Tunnel Release Via Two Small Incisions Comparing With Via Standard Incision And Under Endoscope
CTR
Carpal Tunnel Release With Partial Excision of the Flexor Retinaculum Through Two Small Incisions
1 other identifier
interventional
220
1 country
1
Brief Summary
Carpal Tunnel Release via Two Small Incisions Comparing With via Standard Incision And Under Endoscope.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 12, 2015
CompletedFirst Posted
Study publicly available on registry
July 16, 2015
CompletedJuly 16, 2015
July 1, 2015
3.1 years
July 12, 2015
July 15, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Severity of symptoms and functional status on Boston Questionnaire
2 years
Secondary Outcomes (1)
Grip strength
2 years
Study Arms (3)
Group A
ACTIVE COMPARATORCarpal Tunnel Release via limited approaches with 2 years follow-up.
Group B
ACTIVE COMPARATORCarpal Tunnel Release via standard approach with 2 years follow-up.
Group C
PLACEBO COMPARATOREndoscopic Carpal Tunnel Release with 2 years follow-up.
Interventions
Carpal tunnel release with partial excision of the flexor retinaculum via two small incisions.
Carpal tunnel release with partial excision of the flexor retinaculum via the standard incision.
Eligibility Criteria
You may qualify if:
- Diagnosis of CTR was established based on Evidence for Surgical Treatment issued by the British Society for Surgery of the Hand (2003)
- Patients with moderate, severe, and very severe symptom.
You may not qualify if:
- Mild symptom.
- Finding had a ganglion based on preoperative ultrasound.
- Associated with infection, gout, or diabetes.
- Patients who discontinued intervention and lost to follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The second hospital of Qinhuangdao
Qinhuangdao, Hebei, 066600, China
Related Publications (2)
Notarnicola A, Maccagnano G, Tafuri S, Fiore A, Pesce V, Moretti B. Comparison of shock wave therapy and nutraceutical composed of Echinacea angustifolia, alpha lipoic acid, conjugated linoleic acid and quercetin (perinerv) in patients with carpal tunnel syndrome. Int J Immunopathol Pharmacol. 2015 Jun;28(2):256-62. doi: 10.1177/0394632015584501. Epub 2015 May 7.
PMID: 25953494BACKGROUNDAksekili MA, Bicici V, Isik C, Aksekili H, Ugurlu M, Dogan M. Comparison of early postoperative period electrophysiological and clinical findings following carpal tunnel syndrome: is EMG necessary? Int J Clin Exp Med. 2015 Apr 15;8(4):6267-71. eCollection 2015.
PMID: 26131237RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xu Zhang, MD
The Second Hospital of Qinhunangdao
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2015
First Posted
July 16, 2015
Study Start
January 1, 2010
Primary Completion
February 1, 2013
Study Completion
February 1, 2013
Last Updated
July 16, 2015
Record last verified: 2015-07